Target intelligence / Profile preview

Foot-and-Mouth Disease Virus intact capsid (FMDV 146S)

Target
FMDV 146S
Molecular classification
Viral capsid, Non-enveloped icosahedral virus, Picornavirus structural protein complex
01

Overview

The Foot-and-Mouth Disease Virus (FMDV) intact capsid, also known as the 146S particle, is the structural shell of the virus that encapsulates its single-stranded RNA genome (1.1.1, 1.3.4). It is composed of 60 protomers, each containing four structural proteins: VP1, VP2, VP3, and VP4, which assemble into an icosahedral structure (1.1.2, 1.3.5). The capsid's primary biological function is to protect the viral genome and facilitate entry into host cells by binding to integrin receptors through a conserved Arg-Gly-Asp (RGD) motif located on the VP1 G-H loop (1.1.4, 1.3.3). FMDV causes a highly contagious and economically devastating disease in cloven-hoofed animals, characterized by fever and vesicular lesions (1.3.2, 1.3.4). The 146S particle is the essential component of conventional inactivated vaccines, as its structural integrity is required to induce a potent neutralizing antibody response (1.1.1, 1.5.3). However, the capsid is notoriously unstable, readily dissociating into less immunogenic 12S pentamers when exposed to heat or acidic conditions, which poses significant challenges for vaccine manufacturing and storage (1.1.2, 1.4.2). Therapeutic and preventative strategies focus on using inactivated 146S particles as vaccines, developing neutralizing antibodies that block entry, and engineering more stable capsids to improve vaccine shelf-life and efficacy (1.4.1, 1.4.3).

Other names
FMDV virion146S particleFMDV 146S antigenFoot-and-mouth disease virus capsidFMDV icosahedral shell
02

Mechanism of action

The intact capsid (146S) serves as the primary immunogen in vaccines, eliciting neutralizing antibodies that bind to the capsid surface (particularly the VP1 G-H loop) to block viral attachment to host integrin receptors and prevent subsequent uncoating and RNA release (1.1.2, 1.1.4, 1.4.4).

03

Biological functions

Viral genome protectionCell receptor bindingViral entryViral uncoatingImmune evasion
04

Disease associations

Foot-and-mouth diseaseInfection
05

Safety considerations

Acid lability (dissociation below pH 6.5)Thermal instabilitySerotype-specific immunity (lack of cross-protection)Risk of incomplete inactivation in vaccines
06

Interacting drugs

Inactivated Foot-and-Mouth Disease Virus vaccine

3 more in the full profile.

07

Biomarkers

146S antigen levelsNeutralizing antibody titer (VNT)12S pentamer concentrationVP1-specific antibodies

Beyond the preview

Go deeper on Foot-and-Mouth Disease Virus intact capsid (FMDV 146S).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Foot-and-Mouth Disease Virus intact capsid (FMDV 146S).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call